Evidence map›Paper›PMID 42125503›Full record

ArticleCureus2026

Patient-Reported Symptom Changes Following Structured Intake Advice for Multivitamin-Associated Nausea After Bariatric Surgery.

Ingrid Kruizinga, Aude Pereira, Hendrika Smelt

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ingrid KruizingaMedical Affairs, FitForMe B.V., Rotterdam, NLD.
Aude PereiraCustomer Service, FitForMe B.V., Paris, FRA.
Hendrika SmeltSurgery, Elkerliek Hospital, Helmond, NLD.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Adherence to post-bariatric supplement intake may be affected by tolerability issues. This study aimed to characterize nausea associated with supplement intake and explore the patient-reported symptom course following structured intake instructions in a real-world customer-support context. Methods This retrospective observational study with prospectively collected data consisted of two parts. Part one: a cross-sectional survey of 540 FitForMe customers after bariatric surgery who reported nausea, assessing the timing of supplement intake, the onset and triggers of nausea, and the impact on daily functioning. Part two: a single-arm, uncontrolled follow-up of a separate sample of 75 French FitForMe customers experiencing nausea, who received structured intake instructions during standardized telephone interviews. Recommendations included switching from capsules to chewable tablets, taking supplements with meals, dividing doses, and allowing slower dissolution. The presence of nausea (yes/no) was reassessed by telephone one week later. Results Part one indicated that a large percentage of individuals did not take the supplement according to intake instructions; 256 (47.4%) took it on an empty stomach. Nausea occurred in 93 patients (17.2%) before the actual intake of the supplement. Overall, 365 patients (67.6%) reported a score of 5 or higher on a 0-10 scale measuring the impact on daily life, where 0 indicated no restriction, and 10 indicated being unable to do anything. In part two, at the one-week follow-up, 55 of 75 patients (73.3%) reported resolution of nausea (within-patient comparison, p<0.001). The recommendation most frequently endorsed by patients as perceived to have contributed to their symptom course was switching from capsule to chewable tablet, reported as helpful by 41 of 44 patients who made this switch (93.2%; 54.7% of the total follow-up cohort, n=75; p<0.001). Taking supplements with lunch or dinner was also commonly endorsed (n=42, 56.0%). Additional complaints were common, including potentially dumping-related symptoms (n=30, 40.0%), food intolerance (n=28, 37.3%), and altered taste or smell (n=31, 41.3%). Conclusion In a selected sample of bariatric patients who reported nausea during multivitamin use, incorrect intake practices and multifactorial symptom patterns were common. In a follow-up cohort, structured intake advice was associated with patient-reported resolution of nausea in many participants. While these observational findings do not establish causality, the recommendations are simple, low-cost, and easy to implement, and may be considered as a pragmatic first step in routine post-bariatric care.

Indexed as

adherencebariatric surgerycomplianceintake instructionsmultivitamin supplementationnauseatolerability

Identifiers

PMID42125503
PMCPMC13158632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.